Fructose and NAFLD: The Multifaceted Aspects of  Fructose Metabolism.

Détails

Ressource 1Télécharger: nutrients-09-00230-v2.pdf (803.79 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_B83F96063379
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Fructose and NAFLD: The Multifaceted Aspects of  Fructose Metabolism.
Périodique
Nutrients
Auteur⸱e⸱s
Jegatheesan P., De Bandt J.P.
ISSN
2072-6643 (Electronic)
ISSN-L
2072-6643
Statut éditorial
Publié
Date de publication
03/03/2017
Peer-reviewed
Oui
Volume
9
Numéro
3
Pages
0
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: epublish
Résumé
Among various factors, such as an unhealthy diet or a sedentarity lifestyle, excessive fructose consumption is known to favor nonalcoholic fatty liver disease (NAFLD), as fructose is both a substrate and an inducer of hepatic de novo lipogenesis. The present review presents some well-established mechanisms and new clues to better understand the pathophysiology of fructose-induced NAFLD. Beyond its lipogenic effect, fructose intake is also at the onset of hepatic inflammation and cellular stress, such as oxidative and endoplasmic stress, that are key factors contributing to the progression of simple steatosis to nonalcoholic steatohepatitis (NASH). Beyond its hepatic effects, this carbohydrate may exert direct and indirect effects at the peripheral level. Excessive fructose consumption is associated, for example, with the release by the liver of several key mediators leading to alterations in the communication between the liver and the gut, muscles, and adipose tissue and to disease aggravation. These multifaceted aspects of fructose properties are in part specific to fructose, but are also shared in part with sucrose and glucose present in energy- dense beverages and foods. All these aspects must be taken into account in the development of new therapeutic strategies and thereby to better prevent NAFLD.

Mots-clé
Animals, Combined Modality Therapy, Dietary Carbohydrates/adverse effects, Dietary Carbohydrates/metabolism, Endoplasmic Reticulum Stress, Fructose/adverse effects, Fructose/metabolism, Humans, Lipogenesis, Liver/immunology, Liver/metabolism, Non-alcoholic Fatty Liver Disease/etiology, Non-alcoholic Fatty Liver Disease/immunology, Non-alcoholic Fatty Liver Disease/metabolism, Non-alcoholic Fatty Liver Disease/therapy, Organ Specificity, Oxidative Stress, fructose,  gut,  liver,  muscle,  nonalcoholic fatty liver disease
Pubmed
Web of science
Open Access
Oui
Création de la notice
21/03/2017 20:16
Dernière modification de la notice
20/08/2019 16:26
Données d'usage